Search results
Displaying 11 - 20 of 44 results
-
Update on Ora® product supply shortage (September 2023)
Due to a manufacturing issue, Ora® products are likely to be in limited supply for the coming months before resupply in early November 2023.
-
Patient information - Help us to help you
A leaflet about medicines safety for patients coming into hospital.
-
Metoprolol oral administration - draft alert
The Medication Safety Expert Advisory Group is developing a full alert following release of a safety signal issued in October 2012 on oral metoprolol administration.
-
Safety Signal: Changes to the labelling of Bicillin LA®
Following international practice, the name and strength description for Bicillin LA® has been changed. The expression of the name will now be benzathine benzylpenicillin tetrahydrate. The expression of product strength will now be 1,200,000 units/2.3
-
Consumer research: Safer prescribing and dispensing of medicines
Te Tāhū Hauora Health Quality & Safety Commission (Te Tāhū Hauora) is working alongside other agencies to support safer prescribing and dispensing of medicines. The full report on this project and a summary of the report are available here.
-
Gary's story: a consumer perspective on taking warfarin
This is the story of Gary Edwards, a 60-year-old builder from Waitarere Beach, who ended up on Warfarin after a cardiac event.
-
Safe use of opioids data collection and reporting workbook (manual data capture)
Spreadsheet template for manual data capture, for the safe use of opioids data collection and reporting.
-
Acetylcysteine for the treatment of paracetamol overdose and toxicity – 2-bag dosing guidance
New dosing guidance for acetylcysteine for the treatment of paracetamol overdose and toxicity issued in January 2019.
-
Oxycodone: How did we get here and how do we fix it
This article from Best Practice Journal (July 2014) 'How did we get here and how do we fix it' focuses on the increase in prescribing of oxycodone.
-
Applying for specify brand advice status
Use this application form to apply for a new or changed specify brand advice listing.